HF
BVS icon

HRT Financial’s Bioventus BVS Stock Holding History

HRT Financial’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$532K Sell
56,456
-147,189
-72% -$1.41M ﹤0.01% 2606
2026
Q1 		$1.86M Buy
203,645
+72,996
+56% +$612K ﹤0.01% 1665
2025
Q4 		$972K Buy
+130,649
New +$939K ﹤0.01% 1738
2025
Q2 		– Sell
-22,051
Closed -$201K – 2684
2025
Q1 		$201K Sell
22,051
-20,363
-48% -$203K ﹤0.01% 2030
2024
Q4 		$445K Buy
+42,414
New +$502K ﹤0.01% 1519
2024
Q2 		– Sell
-77,808
Closed -$404K – 2280
2024
Q1 		$404K Buy
+77,808
New +$380K ﹤0.01% 1374
2022
Q2 		– Sell
-83,619
Closed -$1.18M – 2980
2022
Q1 		$1.18M Buy
+83,619
New +$1.12M 0.01% 919
2021
Q4 		– Sell
-14,249
Closed -$201K – 3240
2021
Q3 		$201K Buy
+14,249
New +$219K ﹤0.01% 2688

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's BVS Position: Q2 2026 in Review

HRT Financial reduced its Bioventus (BVS) stake by 72% in Q2 2026, selling an estimated $1.41M and leaving 56,456 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.

HRT Financial first reported a position in BVS in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.86M in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • HRT Financial held 56,456 shares of Bioventus worth $532K as of Q2 2026.
  • HRT Financial sold 147,189 Bioventus shares in Q2 2026, an estimated $1.41M.
  • Bioventus made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2606 holding.
  • HRT Financial first reported a position in Bioventus in Q3 2021 and has held it in 8 quarters since.
  • HRT Financial's Bioventus position peaked at $1.86M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.